PKI News and Press, PerkinElmer Inc. From 01/14/21

Gold-standard testing of individuals without COVID-19 symptoms key to controlling the spread PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer ® New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) from the U....

PerkinElmer (PKI) expects Q4 revenue growth of ~66% vs. consensus of 45.86%, organic revenue growth of ~63%, GAAP EPS of at least $2.88 and adjusted EPS of at least $3.60 vs. consensus of $2.85. The growth is driven by better-than-expected demand for company’s full-suite of COVID-19 an...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of approximately 66% and 63%, respectively, GAAP earnings per share from continuing operations of at least $2.88, and...

Merger activity increased significantly last week with eight new deals announced. The acquisition of Alaska Communications Systems Group by ATN International. The acquisition of FLIR Systems by Teledyne Technologies Incorporated. For further details see: Merger...

Despite a decline next year, COVID-19 testing-related tailwinds could increase in 2021, Wells Fargo points out, projecting vaccine and therapeutic Bioproduction to grow more sustainably than testing through 2023 and beyond.In its 2021outlook for the sector of Life Science Tools, Services, &am...

PerkinElmer (PKI) to acquire Oxford Immunotec for $22/share in cash, for total transaction value of $591M.The acquisition price of $22 represents premium of approximately 28.3% to the closing price per share of USD 17.15 on January 5, 2021.Through this Acquisition, PerkinElmer will grow ...

PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash Transaction expected to be completed in the first half of 2021 PerkinElmer, Inc. (NYSE: PKI) (“ PerkinElmer ”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) (" Oxford Imm...

The U.S. cannabis market is poised for sustained tailwinds after the Democratic party is projected to gain control of the Senate, likely leading to favorable cannabis policy reforms. MSOS holds primarily U.S.-focused cannabis stocks which differentiates itself from the other cannabis ...

Though it has been around for more than 80 years, chances are you've probably never heard of PerkinElmer (NYSE: PKI) -- and that's too bad, because the Waltham, Mass., company is having a great year. PerkinElmer sells high-end laboratory equipment like mass spectrometers and pro...

The market essentially finished flat yesterday while investors wait on a possible new stimulus plan. In the meantime, COVID cases are soaring which could lead to more testing after Christmas and New Years. This could be a boon to stocks such as Hologic, Inc. (HOLX), PerkinElmer, Inc. (PKI), a...